<DOC>
	<DOC>NCT00024258</DOC>
	<brief_summary>RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating children who have advanced neuroblastoma or other solid tumors.</brief_summary>
	<brief_title>Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES: - Determine the response rates of patients with advanced neuroblastoma or other pediatric solid tumors treated with arsenic trioxide. - Determine the toxicity of this drug in these patients. OUTLINE: Patients are stratified according to type of disease (neuroblastoma with progressive disease vs neuroblastoma with stable refractory disease vs other solid tumor). Patients receive arsenic trioxide IV over 1-4 hours on days 1-5 and 8-12. Treatment repeats every 28 days for a maximum of 6 courses in the absence of disease progression or unacceptable toxicity. Patients are followed every 2-3 months for 1 year and then annually thereafter.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Germ Cell and Embryonal</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Arsenic trioxide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Histologically confirmed neuroblastoma or other pediatric solid tumor (nonmyeloid and nonlymphoid) including the following: Ewing's family of tumors/primitive neuroectodermal tumor Retinoblastoma Nephroblastoma Osteosarcoma Rhabdomyosarcoma Desmoplastic small roundcell tumor Hepatoblastoma Germ cell tumors Medulloblastoma Relapsed from or resistant to prior standard anticancer therapy and/or no known standard therapy available Measurable disease (e.g., solid mass with definable dimensions) OR Evaluable disease (e.g., bone marrow involvement or malignant pleural effusion) PATIENT CHARACTERISTICS: Age: 40 and under Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Bilirubin no greater than 2.5 times upper limit of normal (ULN) Renal: Creatinine no greater than 2.5 times ULN Cardiovascular: Absolute QT interval no greater than 460 msec in the presence of adequate potassium and magnesium levels Other: No preexisting neurotoxicity/neuropathy grade 2 or greater No preexisting convulsive disorder No active serious infections uncontrolled by antibiotics Negative pregnancy test Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: More than 3 weeks since prior cytotoxic chemotherapy No other concurrent cytotoxic chemotherapy Endocrine therapy: Not specified Radiotherapy: Concurrent radiotherapy allowed provided measurable or evaluable disease exists outside radiation field Surgery: Not specified Other: No other concurrent investigational agents</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>disseminated neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>stage III childhood liver cancer</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>childhood hepatoblastoma</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>stage V Wilms tumor</keyword>
	<keyword>recurrent Wilms tumor and other childhood kidney tumors</keyword>
	<keyword>intraocular retinoblastoma</keyword>
	<keyword>extraocular retinoblastoma</keyword>
	<keyword>recurrent retinoblastoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>childhood germ cell tumor</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>localized unresectable neuroblastoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>childhood desmoplastic small round cell tumor</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>previously treated childhood rhabdomyosarcoma</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
</DOC>